MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Peripheral unspecific inflammatory parameters – not always useful in differential diagnosis of parkinsonian syndromes.

    N. Madetko-Alster, P. Alster (Warsaw, Poland)

    Objective: To determine utility of systemic inflammation response index (SIRI) and systemic immune-inflammation index (SII) in differential diagnosis of Parkinson’s disease (PD), progressive supranuclear palsy-Richardson’s…
  • 2025 International Congress

    Plasma tau-species-containing neuron-derived extracellular vesicles as potential biomarkers for progressive supranuclear palsy

    YC. Zheng, HH. Cai, WY. Kou, ZW. Yu, T. Feng (Beijing, China)

    Objective: This study aimed to develop and validate novel plasma PSP biomarkers based on tau-species-containing neuron-derived extracellular vesicles (NDEVs) in two independent cohorts (discovery and…
  • 2025 International Congress

    Differences Between Clinical and Imaging Phenotypes in Phase 2 Study of ATH434 in Multiple System Atrophy

    P. Trujillo, K. Hett, M. Bradbury, C. Wong, D. Stamler, D. Claassen (Nashville, USA)

    Objective: To assess differences between clinical and imaging phenotypes in Multiple System Atrophy (MSA) and evaluate the reliability of imaging biomarkers for subtype classification. Background:…
  • 2025 International Congress

    Case report and Literature Review on Atypical Parkinson’s Disease

    MJ. Dashdorj (Ulaanbaatar, Mongolia)

    Objective: Atypical parkinsonism is classified as a subgroup of Progressive neurodegenerative diseases, characterized by symptoms of Parkinson's disease. Background: Progressive supra nuclear palsy of the…
  • 2025 International Congress

    Identification of Genetic Variants in Progressive Supranuclear Palsy in China

    Y. Kang, W. Luo (Hangzhou, China)

    Objective: To delineate the genetic landscape of progressive supranuclear palsy (PSP) in Chinese patients.Progressive supranuclear palsy is a neurodegenerative disorder primarily considered sporadic, with MAPT…
  • 2025 International Congress

    The effectiveness and safety of autologous adipose derived stromal vascular components (SVF) in the treatment of multiple system atrophy

    ZL. Cai, RX. Li, JW. Li (Suzhou, China)

    Objective: This study aimed to explore the efficacy and safety of autologous adipose - derived stromal vascular fraction (SVF) in treating MSA. Background: Multisystem atrophy…
  • 2025 International Congress

    Treatment of Status Dystonicus with Deep Brain Stimulation in a Child with SOX2-Anophthalmia Syndrome

    A. Morris, A. Viehoever (Saint Louis, USA)

    Objective: To report on the clinical course and outcomes following bilateral globus pallidus pars interna deep brain stimulation (GPi DBS) in a child with SOX2-anophthalmia…
  • 2025 International Congress

    Ataxia in PBC: The Overlooked Role of Fat-Soluble Vitamin Deficiency

    M. Rajani, P. Prakash (Providence, USA)

    Objective: To describe the investigation of ataxia in a patient with primary biliary cholangitis (PBC) despite ursodeoxycholic acid (UDCA) treatment. Background: PBC is an autoimmune…
  • 2025 International Congress

    Phenotypic Spectrum of Movement Disorders in TBC1D24 Gene Variants: A Case Series

    K. Chesky, M. Parnes, M. Hull (Houston, USA)

    Objective: To report the phenotypic spectrum of movement disorders in 5 pediatric patients with TBC1D24 gene variants and provide accompanying video. Background: The TBC1D24 gene…
  • 2025 International Congress

    Effectiveness of Intensive Speech Treatment for Friedreich’s Ataxia

    L. Ramig, H. Hodges, E. Peterson, M. Tran, A. Lowit (Tucson, USA)

    Objective: ​​​​​​1. Test feasibility of providing online intensive speech treatment to people with Friedreich’s Ataxia (FA)2. Compare benefits of two treatment targets (vocal loudness-LSVT LOUD;…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley